Effects of statins on cognitive function in patients with Alzheimer's disease in galantamine clinical trials.
BACKGROUND AND OBJECTIVE: A number of reports have been published on the possible involvement of changes in brain cholesterol metabolism in the origin of Alzheimer's disease (AD) and the potential for influencing these changes by administration of HMG-CoA reductase inhibitors ('statins'). The aim of...
| Publicado en: | Drugs & Aging Vol. 24; no. 1; pp. 57 - 62 |
|---|---|
| Autores principales: | , , , |
| Formato: | research Journal Article |
| Publicado: |
Springer Nature
2007
|
| Acceso en línea: | Ver este registro en EBSCOhost |